admin

Sheikh Tahnoon bin Zayed Tops Gulf Power List as UAE Doubling Down on Tech-Driven Sovereign Strategy

Sheikh Tahnoon bin Zayed: Pioneering a New Era of Tech Investment In the rapidly evolving landscape of global finance and technology, few figures stand out as prominently as Sheikh Tahnoon bin Zayed Al Nahyan of the United Arab Emirates. As the leading figure in Gulf Business’s 2025 power list, Sheikh Tahnoon represents a transformative shift […]

Sheikh Tahnoon bin Zayed Tops Gulf Power List as UAE Doubling Down on Tech-Driven Sovereign Strategy Read More »

EY Slammed with Fine for Audit of Scottish Water Company

EY Faces Regulatory Penalties for Audit Exaggerations Ernst & Young (EY), one of the largest professional services firms in the world, has recently been penalized by the Financial Reporting Council (FRC) for significant inaccuracies in its audit practices. The penalty of £500,000 was reduced to £325,000 after a detailed review of the circumstances surrounding the

EY Slammed with Fine for Audit of Scottish Water Company Read More »

Barclays shares skyrocket as FTSE 100 bounces back from tariff shock

Barclays Shares Experience Significant Surge Following Tariff Changes In a remarkable turn of events, shares of Barclays surged by over 20% at the market open, eventually stabilizing at a 15% increase. This rebound reflects a broader recovery in the FTSE 100 index following the removal of tariffs previously imposed by the Trump administration. The lifting

Barclays shares skyrocket as FTSE 100 bounces back from tariff shock Read More »

Scinai Immunotherapeutics into binding option agreement to acquire Pincell srl

Scinai Immunotherapeutics acquiert Pincell srl pour une avancée majeure dans le traitement des maladies cutanées Dans un développement prometteur pour le secteur de la biopharmaceutique, Scinai Immunotherapeutics a annoncé la signature d’un accord d’option contraignant pour acquérir Pincell srl. Cette acquisition stratégique met l’accent sur PC111, un anticorps monoclonal thérapeutique destiné à traiter des maladies

Scinai Immunotherapeutics into binding option agreement to acquire Pincell srl Read More »